Compounds > emd 53998

Page last updated: 2024-09-05

emd 53998 and 3'-o-(n-methylanthraniloyl) atp

emd 53998 has been researched along with 3'-o-(n-methylanthraniloyl) atp in 1 studies

Compound Research Comparison

Studies (emd 53998)	Trials (emd 53998)	Recent Studies (post-2010) (emd 53998)	Studies (3'-o-(n-methylanthraniloyl) atp)	Trials (3'-o-(n-methylanthraniloyl) atp)	Recent Studies (post-2010) (3'-o-(n-methylanthraniloyl) atp)
112	0	9	73	0	16

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Beck, T; Campbell, KS; Hessel, AL; Iwamoto, H; Lewis, CTA; Ochala, J; Pyle, WG	1

Other Studies

1 other study(ies) available for emd 53998 and 3'-o-(n-methylanthraniloyl) atp

Article	Year
Predominant myosin superrelaxed state in canine myocardium with naturally occurring dilated cardiomyopathy. American journal of physiology. Heart and circulatory physiology, 2023, 09-01, Volume: 325, Issue:3 Topics: Adenosine Triphosphate; Animals; Cardiomyopathy, Dilated; Dogs; Humans; Myocardium; Myosins	2023